Good news! The European Union's most authoritative, the most rigorous experimental research institute (Germany PEI), performance verification has been passed!
Recently, the Novel Coronavirus (2019-NCOV) Antigen test (Colloidal gold method) independently developed by BaIBO Biological (Stock code: 830774) has passed the performance verification of the Paul-Ehrlich Institute (German: Paul-Ehrlich Institut). The test kit (colloidal gold method) was validated by the Paul-Ehrlich Institute (PEI) in Germany.
Germany Paul Ehrlich institute (PEI) and the German federal vaccines and biomedical research institute, is one of Germany's federal research institutions and medical regulators, currently affiliated with the federal ministry of health (BMG), has the independent exercise of biological products inspection, clinical trials for examination and approval, approved and issued by batch products, such as functions, but also for different organizations, In particular, it provides scientific advice on the drafting and revision of relevant regulations in some EU countries, EU and international committees. It also provides professional advice to the German government, local authorities and the German Parliament, and provides relevant information to patients and consumers.
This time, The Biocov antigen test has been granted the PEI authoritative certification, which fully demonstrates the excellent performance of the product. At present, the epidemic situation is still severe. Biocov COVID-19 test products will continue to contribute to the rapid screening of novel Coronavirus and contribute to the fight against COVID-19.